Last November, GlaxoSmithKline reported a disappointing 30 percent effectiveness in a trial for its RTS,S anti-malarial vaccine.
Using nanotechnology to study malaria
Wednesday, February 6, 2013 - 7:00pm
Dr Ming Dao, Research Scientist, integrates nano-mechanics and bioengineering to study the parasites that cause malaria. See the MIT Industrial Liaison site for an article about his research.
Nanoparticle vaccine offers better protection
Wednesday, September 25, 2013 - 8:00pm
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases. See the News Office for the full story.
Gold nanoparticles in medical use
Sunday, July 20, 2014 - 8:00pm
Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs. See the MIT News Office for the full story.
Pharmacy on a chip
Thursday, April 24, 2014 - 8:00pm
CNN spotlighted MicroCHIPS, a company working on implantable devices that deliver medications as controlled by a doctor.
Monday, February 17, 2014 - 7:00pm
Professor Darrell Irvine has published research on new vaccines that catch a ride to immune cell depots in order to help fight cancer and HIV.
New discoveries in how immune system fights malaria
Monday, January 13, 2014 - 7:00pm
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
Magnetic brain stimulation
Wednesday, March 11, 2015 - 8:00pm
New technique could lead to long-lasting localized stimulation of brain tissue without external connections.
Better chemotherapy through targeted delivery
Sunday, October 26, 2014 - 8:00pm
Every year, about 100,000 Americans are diagnosed with brain tumors that have spread from elsewhere in the body. These tumors, known as metastases, are usually treated with surgery followed by chemotherapy, but the cancer often returns.
Shape-memory materials used to treat disease
Wednesday, October 15, 2014 - 8:00pm
The millions of people worldwide who suffer from the painful bladder disease known as interstitial cystitis (IC) may soon have a better, long-term treatment option, thanks to a controlled-release, implantable device invented by MIT professor Michael Cima and other researchers.